Lake Street Capital Cuts Aquestive Therapeutics (NASDAQ:AQST) Price Target to $8.00
Aquestive Therapeutics (NASDAQ:AQST – Free Report) had its target price cut by Lake Street Capital from $10.00 to $8.00 in a research report report published on Friday morning,Benzinga reports. They currently have a buy rating on the stock. Other equities analysts have also recently issued research reports about the company. Cantor Fitzgerald started coverage on […]
Aquestive Therapeutics (NASDAQ:AQST – Free Report) had its target price cut by Lake Street Capital from $10.00 to $8.00 in a research report report published on Friday morning,Benzinga reports. They currently have a buy rating on the stock. Other equities analysts have also recently issued research reports about the company. Cantor Fitzgerald started coverage on […]
